Picture of Leonteq AG logo

LEON Leonteq AG News Story

0.000.00%
ch flag iconLast trade - 00:00
FinancialsSpeculativeSmall CapTurnaround

Swiss stocks - Factors to watch on January 18

ZURICH/BERLIN, Jan 18 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Tuesday:
    
    LINDT & SPRUENGLI  LISN.S  
    Swiss chocolate maker Lindt & Spruengli on Tuesday confirmed
its 2021 margin guidance and said it wanted to grow sales by
5-7% this year after market share gains helped organic sales
rise 13.3% in 2021.  urn:newsml:reuters.com:*:nL8N2TY0N9
    
    CREDIT SUISSE  CSGN.S 
    New Credit Suisse Chairman Axel Lehmann, appointed to the
top role in an abrupt change on Monday, believes the embattled
lender will continue as an independent bank, he said in an
interview published on Tuesday. "We continue to focus on our
strategy, which is based on the Swiss business and wealth
management. The signal to the market is that we see the future
of CS as an independent bank," Lehmann told Swiss newspaper
Tages-Anzeiger.  CSGN.S  
    His predecessor was forced to resign after barely eight
months in office for flouting coronavirus quarantine rules in
both Britain and Switzerland.  urn:newsml:reuters.com:*:nL1N2TX1DC
      
    COMPANY STATEMENTS
    * Molecular Partners  MOLN.S  said it finalised a licence
agreement with Novartis  NOVN.S  granting Novartis global rights
to lead further development and commercialisation of Ensovibep
to treat COVID-19 patients, including a 150 million franc
milestone payment and 22% royalty.  MOLN.S   NOVN.S 
    * Leonteq  LEON.S  said it started a cooperation with
Swissquote to distribute structured products.  LEON.S 
    * GAM Holding  GAMH.S  said it expected to report a roughly
30 million franc net loss for 2021 when it reports results on
Feb. 17.  GAMH.S 
    * Vifor Pharma  VIFN.S  said the offer period for its
takeover offer by CSL Behring was expected to run Feb. 2 through
March 2.  VIFN.S 
    * Ionis Pharmaceuticals said partner Roche  ROG.S  would
evaluate the use Tominersen for Huntington's disease in a new
phase II trial.  ROG.S 
    * Luzerner Kantonalbank  LUKN.S  said it would make changes
to its organisational structure in 2023.  LUKN.S 
   
    ANALYST VIEWS
    JULIUS BAER GRUPPE AG  BAER.S : CITIGROUP RAISES PRICE
TARGET TO  CHF 75 FROM  CHF 74
    
    ECONOMY
    Swiss December Producer/Import price index data due at 0730
GMT.


 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))

Recent news on Leonteq AG

See all news